Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
1.
Balkan Med J ; 36(2): 88-95, 2019 02 28.
Artículo en Inglés | MEDLINE | ID: mdl-30322831

RESUMEN

Background: Postoperative complications occur after periodontal plastic surgeries, but an ideal treatment to overcome them has not been found yet. Aims: To evaluate the effects of topically applied Oral-norm gel on the healing of excisional wounds. Study Design: Animal experiment. Methods: Excisional wounds with a diameter of 3 mm were made in the center of the palatal mucosa of 63 Sprague Dawley rats. Seven animals were sacrificed at time 0. The remaining rats were divided into two groups: a test group in which the topical Oral-norm gel was applied three times a day and a control group in which nothing was applied. Seven animals in each group were sacrificed at 3, 7, 14, and 21 days. Mean wound surface area was measured photographically, while wound healing and width were evaluated microscopically. Results: The mean wound surface area decreased significantly after 3 days in both groups (p<0.001). Between days 3 and 7, the mean wound surface area decreased from 6.62 (2.85) to 0.83 (1.62) mm2 in the control group and 5.07 (0.88) to 1.42 (1.67) mm2 in the test group. The wound width decreased significantly on day 7 in both groups (p<0.001), with no further changes by day 14. Both groups had a significant increase in inflammation and vascularization on day 3 (p<0.001), with a reduction thereafter. No significant differences in macroscopic and microscopic measurements were observed between the groups at any time point (p>0.05). Conclusion: The Oral-norm gel has no positive healing effects in the palatal mucosa of rats.


Asunto(s)
Administración Tópica , Combinación de Medicamentos , Hueso Paladar/efectos de los fármacos , Cicatrización de Heridas , Animales , Modelos Animales de Enfermedad , Lidocaína/farmacología , Lidocaína/uso terapéutico , Hueso Paladar/lesiones , Ácido Pantoténico/análogos & derivados , Ácido Pantoténico/farmacología , Ácido Pantoténico/uso terapéutico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Ratas Sprague-Dawley/lesiones , Ácidos Undecilénicos/farmacología , Ácidos Undecilénicos/uso terapéutico
2.
J Burn Care Res ; 39(3): 413-422, 2018 04 20.
Artículo en Inglés | MEDLINE | ID: mdl-29897542

RESUMEN

An enzyme mixture containing bromelain (NexoBrid®) was found to be suitable for enzymatic debridement of burn wounds, as determined by the criteria of patient comfort and pain, selectivity, and efficiency. Nevertheless, daily experience showed that pretreatment of burn wounds with several other clinical agents may inhibit debridement efficiency. Therefore, the current study was performed to identify those agents and evaluate their debridement inhibition capabilities. The impact of several common agents as well pH, on NexoBrid® debridement efficiency was evaluated in vitro. A collagen-based dermal substitute (MatriDerm®) was exposed to NexoBrid® in the presence of different agents of varying concentrations. Digestion was documented. The criteria used for judging digestion were independently classified by 3 investigators at least 3 times in succession. When a low concentration (1.0 mg/ml) of NexoBrid® was used, a ≥ 50% concentration of Prontosan® had an impact on enzymatic activity. Comparable results were obtained when even lower concentrations of Octenisept® (≥ 10%) were used. A 100-µmol/L concentration of copper inhibited the enzymatic activity of both a low (1.0 mg/ml) and high (10 mg/ml) concentration of NexoBrid®. Silver-sulfadiazine at concentrations of 10% and 90% inhibited the activity of 1 mg/ml NexoBrid®. No complete inhibition of NexoBrid® activity occurred at any concentration of iron. We recommend using polyhexanide-containing agents (Prontosan®) to rinse and presoak burn wounds. Pretreatment of burn wounds with agents containing silver and copper should be avoided. Experimentally, we found a partial inhibition of NexoBrid® activity at the distinct pH values of 3 and 11.


Asunto(s)
Antiinfecciosos Locales/química , Bromelaínas/química , Quemaduras/terapia , Desbridamiento/métodos , Antiinfecciosos Locales/uso terapéutico , Betaína/análogos & derivados , Betaína/química , Betaína/uso terapéutico , Biguanidas/química , Biguanidas/uso terapéutico , Bromelaínas/uso terapéutico , Colágeno/química , Colágeno/uso terapéutico , Elastina/química , Elastina/uso terapéutico , Etanolaminas/química , Etanolaminas/uso terapéutico , Iminas , Piridinas/química , Piridinas/uso terapéutico , Piel Artificial , Ácidos Undecilénicos/química , Ácidos Undecilénicos/uso terapéutico
3.
Rev. cuba. farm ; 48(2)abr.-jun. 2014. tab, graf
Artículo en Español | CUMED | ID: cum-63992

RESUMEN

Introducción: Fungirex crema es un producto que contiene dos fármacos: ácido undecilénico y undecilenato de zinc en una base adecuada. Como se trata de un producto que no aparece en las monografías oficiales de las farmacopeas, se proponen métodos analíticos sencillos capaces de cuantificar los analitos de interés en la crema, útiles para la liberación de los lotes de crema recién elaborados.Objetivo: validar dos métodos volumétricos para control de calidad de los ingredientes activos presentes en Fungirex crema. Métodos: se propuso una volumetría de neutralización directa para cuantificar ácido undecilénico previa extracción del analito y la complejometría con EDTA para undecilenato de zinc. Atendiendo a la clasificación de ambos métodos en la categoría I, se realizó la validación de ambos métodos a través de los parámetros: especificidad, linealidad, exactitud, precisión y rango. Resultados: se corroboró la ausencia de interferencia de los restantes componentes de la matriz. Los criterios de aceptación establecidos para linealidad, exactitud y precisión se cumplieron satisfactoriamente para los dos métodos en estudio, por lo que fueron válidos en el rango de 50 a 150 por ciento (método por volumetría de neutralización: 25,6-76,8 mg/g y método por complejometría: 111,1-333,3 mg/g). Conclusiones: los métodos volumétricos propuestos fueron lineales, precisos, exactos y específicos para realizar el control de calidad de Fungirex crema en base al contenido de ácido undecilénico y undecilenato de zinc(AU)


Introduction: Fungirex cream is a two-drug product, that is, undecylenic acid and zinc undecylenate over a suitable basis. Since this is a product not documented in the official monographs of the pharmacopeae, simple analytical methods were suggested for quantitation of analytes of interest in the cream, which are useful for release of newly prepared cream batches. Objective: to validate two volumetric methods for the quality control of active ingredients in Fungirex cream. Methods: a direct neutralization volumetric method was suggested to quantitate undecylenic acid after the analyte extraction and EDTA complexometry for zinc undecylenate . According to the classification of both methods in the category I, they were validated through the parameters specificity, linearity, accuracy, precision and range. Results: the non-interference of the rest of the matrix components was corroborated. The set acceptance criteria for linearity, accuracy and precision were satisfactorily met for the two study methods, so they were valid in the 50-150 percent range (neutralization volumetry method: 25.6-76.8 mg/g and complexometry method 111.1-333,3 mg/g). Conclusions: the suggested volumetric methods were linear, specific, precise, and accurate for the quality control of Fungirex cream based on the undecylenic acid and zinc undecylenate content(AU)


Asunto(s)
Ácidos Undecilénicos/uso terapéutico , Control de Calidad , Estudios de Validación como Asunto
4.
Rev. cuba. farm ; 48(2)abr.-jun. 2014. tab, Ilus
Artículo en Español | LILACS, CUMED | ID: lil-731956

RESUMEN

INTRODUCCIÓN: Fungirex crema es un producto que contiene dos fármacos: ácido undecilénico y undecilenato de zinc en una base adecuada. Como se trata de un producto que no aparece en las monografías oficiales de las farmacopeas, se proponen métodos analíticos sencillos capaces de cuantificar los analitos de interés en la crema, útiles para la liberación de los lotes de crema recién elaborados. OBJETIVO: validar dos métodos volumétricos para control de calidad de los ingredientes activos presentes en Fungirex crema. MÉTODOS: se propuso una volumetría de neutralización directa para cuantificar ácido undecilénico previa extracción del analito y la complejometría con EDTA para undecilenato de zinc. Atendiendo a la clasificación de ambos métodos en la categoría I, se realizó la validación de ambos métodos a través de los parámetros: especificidad, linealidad, exactitud, precisión y rango. RESULTADOS: se corroboró la ausencia de interferencia de los restantes componentes de la matriz. Los criterios de aceptación establecidos para linealidad, exactitud y precisión se cumplieron satisfactoriamente para los dos métodos en estudio, por lo que fueron válidos en el rango de 50 a 150 por ciento (método por volumetría de neutralización: 25,6-76,8 mg/g y método por complejometría: 111,1-333,3 mg/g). CONCLUSIONES: los métodos volumétricos propuestos fueron lineales, precisos, exactos y específicos para realizar el control de calidad de Fungirex crema en base al contenido de ácido undecilénico y undecilenato de zinc(AU)


INTRODUCTION: Fungirex cream is a two-drug product, that is, undecylenic acid and zinc undecylenate over a suitable basis. Since this is a product not documented in the official monographs of the pharmacopeae, simple analytical methods were suggested for quantitation of analytes of interest in the cream, which are useful for release of newly prepared cream batches. OBJECTIVE: to validate two volumetric methods for the quality control of active ingredients in Fungirex cream. METHODS: a direct neutralization volumetric method was suggested to quantitate undecylenic acid after the analyte extraction and EDTA complexometry for zinc undecylenate . According to the classification of both methods in the category I, they were validated through the parameters specificity, linearity, accuracy, precision and range. RESULTS: the non-interference of the rest of the matrix components was corroborated. The set acceptance criteria for linearity, accuracy and precision were satisfactorily met for the two study methods, so they were valid in the 50-150 percent range (neutralization volumetry method: 25.6-76.8 mg/g and complexometry method 111.1-333,3 mg/g). CONCLUSIONS: the suggested volumetric methods were linear, specific, precise, and accurate for the quality control of Fungirex cream based on the undecylenic acid and zinc undecylenate content(AU)


Asunto(s)
Humanos , Control de Calidad , Ácidos Undecilénicos/uso terapéutico , Medicamentos de Referencia , Estudios de Validación como Asunto
5.
Eur J Pharm Sci ; 46(1-2): 17-25, 2012 May 12.
Artículo en Inglés | MEDLINE | ID: mdl-22333440

RESUMEN

The key neuropathological features of Alzheimer's disease are abnormal deposition of Aß plaques and insoluble Aß peptides in extracellular brain and intracellular neurofibril tangles induced by abnormal tau hyperphosphorylation. µ-Calpain is one of the factors that bridge these Aß- and hyperphosphorylated tau-mediated pathological pathways. Undecylenic acid (UDA), a naturally occurring unsaturated fatty acid, was discovered as a µ-calpain inhibitor by screening a chemical library using a substrate specific µ-calpain assay method. UDA inhibited Aß oligomerization and Aß fibrillation and reversed Aß-induced neuronal cell death. In addition, UDA scavenged ROS and reversed the levels of proapoptotic proteins induced by ROS in SH-SY5Y cells. UDA inhibited µ-calpain activity with better potency than the known peptide-like µ-calpain inhibitor, MDL28170, in SH-SY5Y and HEK293T cells transfected with the catalytic subunit of µ-calpain. These results suggest that UDA is a novel non-peptide-like µ-calpain inhibitor with good cell permeability and potent neuroprotective effect.


Asunto(s)
Péptidos beta-Amiloides/antagonistas & inhibidores , Calpaína/antagonistas & inhibidores , Supervivencia Celular/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Ácidos Undecilénicos/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Interpretación Estadística de Datos , Dipéptidos/farmacología , Descubrimiento de Drogas , Células HEK293 , Humanos , Microscopía de Fuerza Atómica , Neuronas/efectos de los fármacos , Neuronas/enzimología , Fármacos Neuroprotectores/uso terapéutico , Permeabilidad/efectos de los fármacos , Placa Amiloide/tratamiento farmacológico , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Ricinus/química , Bibliotecas de Moléculas Pequeñas , Ácidos Undecilénicos/uso terapéutico
6.
Rev. Rol enferm ; 31(2): 100-101, feb. 2008.
Artículo en Español | IBECS | ID: ibc-79029

RESUMEN

Se evalúa una solución y gel formulados con undecilamidopropilbetaína y polihexanida, indicados en la limpieza y descontaminación de heridas, sin efecto citotóxico, irritante o sensibilizante alguno, que favorecen y estimulan el proceso natural de cicatrización(AU)


The authors evaluate a solution and a gel composed of undecylenate prophyl betaine and polyhexanide recommended for cleansing and decontaminating injuries, without having any cytotoxic, irritating or sensibility effect which favors and stimulates the natural cicatrization process(AU)


Asunto(s)
Humanos , Cicatrización de Heridas , Infección de Heridas/tratamiento farmacológico , Desinfectantes/uso terapéutico , Desbridamiento/enfermería , Desinfección/métodos , Geles/uso terapéutico , Ácidos Undecilénicos/uso terapéutico
7.
Br J Nurs ; 15(22): 1222, 1224-8, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17346020

RESUMEN

Chronic wounds present a challenge that is costly in terms of quality of life to the patient and in financial terms for the NHS. Several factors contribute to the development of a chronic wound, in particular the influence of bacteria as a biofilm within the wound environment. Irrigating a wound with normal saline has long been advocated as the most appropriate method of wound irrigation but biofilms are now known to be resistant to this method of cleansing. A small (10 patient) evaluation of the use of Prontosan in patients whose duration of chronic wounds exceeded 1 year has demonstrated that Prontosan wound irrigation and Prontosan gel are an appropriate alternative for cleaning, moistening and decontaminating encrusted, contaminated and chronic skin wounds, and can have a dramatic influence of the quality of life for such patients. This article discusses the cause of chronicity within a wound and discusses in depth three of the ten patients in the evaluation.


Asunto(s)
Biguanidas/uso terapéutico , Cuidados de la Piel/métodos , Tensoactivos/uso terapéutico , Irrigación Terapéutica/métodos , Infección de Heridas/prevención & control , Administración Cutánea , Anciano , Anciano de 80 o más Años , Betaína/uso terapéutico , Biopelículas , Enfermedad Crónica , Combinación de Medicamentos , Femenino , Geles , Humanos , Control de Infecciones/métodos , Masculino , Calidad de Vida , Compuestos de Plata/uso terapéutico , Cuidados de la Piel/enfermería , Irrigación Terapéutica/enfermería , Resultado del Tratamiento , Ácidos Undecilénicos/uso terapéutico , Cicatrización de Heridas , Infección de Heridas/psicología
9.
Antiviral Res ; 40(3): 139-44, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10027648

RESUMEN

There is increasing interest in the use of topical microbicides to help prevent the spread of sexually transmitted diseases (STD). Undecylenic acid (UA), a monosaturated fatty acid, is the active ingredient in a number of over-the-counter (OTC) antifungal spray powders, that also exhibits in vitro antibacterial and antiviral activity, including herpes simplex virus (HSV) activity. We, therefore, evaluated UA as a topical microbicide against genital HSV infection using the murine and guinea pig models of genital herpes. Mice were administered a 20% solution of UA in polyethylene glycol (PEG) vehicle, vehicle alone or phosphate buffered saline (PBS) intravaginally immediately prior to vaginal challenge with HSV-2. Pre-treatment with UA decreased the number of mice that became infected (P < 0.001 vs. PBS or vehicle control), developed symptoms (P <0.001) or died (P <0.001). However, when treatment was extended to either 5 min prior to or after viral inoculation, protection was lost. Similar findings were found using the guinea pig model, where UA treatment completely prevented HSV-2 vaginal infection when given immediately prior to HSV-2 inoculation (P<0.001 vs. PBS or vehicle control). Thus, UA, an approved OTC medication, provided significant protection against HSV disease and infection only when applied immediately before viral inoculation, indicating that better formulations were needed to extend the duration of protection.


Asunto(s)
Antivirales/uso terapéutico , Herpes Genital/tratamiento farmacológico , Ácidos Undecilénicos/uso terapéutico , Administración Tópica , Animales , Antivirales/administración & dosificación , Modelos Animales de Enfermedad , Femenino , Cobayas , Herpes Genital/prevención & control , Ratones , Resultado del Tratamiento , Ácidos Undecilénicos/administración & dosificación , Vagina/virología
10.
11.
J Med Chem ; 33(1): 430-4, 1990 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2296033

RESUMEN

A series of 7 alpha-undecylestradiol derivatives, featuring various substituents at the end of the undecyl spacer chain, were synthesized and evaluated for their interaction with the estrogen receptor and nonreceptor sites. Their relative binding affinities (RBA) for calf uterine estrogen receptors were measured by competitive binding assays and varied between 0.5 and 8.4% of that of unlabeled 17 beta-estradiol. Enhanced lipophilicity and steric hindrance of the substituent on the end of the spacer chain resulted in decreased binding affinity for the estrogen receptor, while interactions with nonreceptor sites increased. RBA values were not affected by prolonged incubation times, suggesting a stable ligand-receptor complex. The potential to use the 7 alpha-undecylestradiol as a vector for site-selective delivery of diagnostic and therapeutic moieties to estrogen-receptor-positive human cancers is discussed.


Asunto(s)
Neoplasias de la Mama/análisis , Estradiol/análogos & derivados , Receptores de Estrógenos/metabolismo , Ácidos Undecilénicos/metabolismo , Animales , Unión Competitiva , Neoplasias de la Mama/tratamiento farmacológico , Bovinos , Fenómenos Químicos , Química , Estradiol/síntesis química , Estradiol/metabolismo , Estradiol/uso terapéutico , Femenino , Estructura Molecular , Receptores de Estrógenos/análisis , Relación Estructura-Actividad , Ácidos Undecilénicos/síntesis química , Ácidos Undecilénicos/uso terapéutico , Útero/metabolismo
14.
Mycopathologia ; 73(2): 105-8, 1981 Feb 13.
Artículo en Inglés | MEDLINE | ID: mdl-7219512

RESUMEN

Microsporum canis was isolated from the inflammatory skin lesions of a Bengal tiger in April, 1979. In clinical findings rounded area of alopecia, 3 to 8 cm in size was observed on the right haunch and the tail. The skin lesions were covered with thin scales, but the inflammatory changes were not severe. Findings, on physical examination, were unremarkable and the animal appeared healthy except for the skin lesions. The infected hairs were invaded by the fungal elements and arthroconidia were around the hair shaft. Cuticles and cortex of the infected hairs were brittle. They were evidently digested and were easily pulled out from the hair follicles. In mycological findings numerous and typical macroconidia were observed. By cross mating of a isolate from tiger and Nannizzia otae(-) strains, cleistothecia were produced. Both organic iodide and undecylenic acid ointment were effective for therapy. In this paper the dermatophytosis of tiger caused by M. canis is described.


Asunto(s)
Carnívoros/microbiología , Dermatomicosis/veterinaria , Microsporum/aislamiento & purificación , Animales , Dermatomicosis/tratamiento farmacológico , Dermatomicosis/microbiología , Femenino , Hidrocarburos Yodados/uso terapéutico , Microsporum/citología , Ácidos Undecilénicos/uso terapéutico
15.
Cutis ; 25(5): 544-6, 549, 1980 May.
Artículo en Inglés | MEDLINE | ID: mdl-6991217

RESUMEN

A double-blind parallel study comparing tolnaftate cream with undecylenic acid ointment and a placebo ointment in the treatment of symptomatic tinea pedis was conducted on the warm, humid Texas Gulf Coast. In one hundred and three patients studied, both the clinical and mycological effects of the two antifungal agents were indistinguishable. Both were significantly more effective than the placebo.


Asunto(s)
Tiña del Pie/tratamiento farmacológico , Tolnaftato/uso terapéutico , Ácidos Undecilénicos/uso terapéutico , Ensayos Clínicos como Asunto , Método Doble Ciego , Humanos , Masculino , Pomadas , Tiña del Pie/microbiología , Tolnaftato/administración & dosificación , Ácidos Undecilénicos/administración & dosificación
17.
Int J Dermatol ; 19(1): 51-4, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-6987185

RESUMEN

One hundred fifty-one patients with tinea pedis participated in a double-blind study to assess the efficacy and safety of a powder containing undecylenic acid 2% and zinc undecylenate 20% versus a placebo powder. Patients were assigned to apply twice-daily applications of either active powder or placebo for a period of 4 weeks. Trichophyton rubrum or Trichophyton mentagrophytes were isolated from pretreatment cultures of 85 patients. Of these, 88% treated with active powder had negative cultures after 4 weeks compared with 17% of those treated with placebo powder (p less than 0.001). Fungus was identified in potassium hydroxide (KOH) treated skin scrapings of all 151 patients before treatment. Of those treated with active powder, 80% were KOH negative after 4 weeks compared with 49% of those treated with placebow powder (p = 0.001). Erythema and scaling were significantly improved by therapy with active powder, as were subjective evaluations of itching and burning. There were no side-effects or adverse reactions to undecylenic acid and its zinc salt.


Asunto(s)
Tiña del Pie/tratamiento farmacológico , Ácidos Undecilénicos/uso terapéutico , Ensayos Clínicos como Asunto , Método Doble Ciego , Humanos , Placebos , Zinc/uso terapéutico
18.
Cutis ; 23(5): 696-8, 1979 May.
Artículo en Inglés | MEDLINE | ID: mdl-378561

RESUMEN

To evaluate the relative effectiveness of the treatment of tinea pedis, we performed a double-blind study comparing undecylenic acid ointment, tolnaftate cream, and a placebo. Ninety patients with clinically and mycologically proven tinea pedis took part in this clinical trial. Our results showed both agents to be superior to the placebo, but there was no significant difference in effectiveness between the two active agents. We observed no side effects with the preparations used.


Asunto(s)
Tiña del Pie/tratamiento farmacológico , Tolnaftato/uso terapéutico , Ácidos Undecilénicos/uso terapéutico , Ensayos Clínicos como Asunto , Método Doble Ciego , Humanos , Medicamentos sin Prescripción , Placebos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...